CoChat
Sign Up
Cited by 10

The DOI matches its Crossref record.

Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?

·2013·Journal of Clinical and Translational Hepatology
DOI 10.14218/jcth.2013.d002xPMC PMC4521275
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14218/jcth.2013.d002x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 59

  1. [1]Aronson JK Talbot J Aronson JK Adverse drug reactions: History, terminology, classification, causality, frequency, preventability Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice 2011 6th Edition New York John Wiley & Sons, Ltd 1 119
  2. [2]Aronson JK Meyler's side effects of herbal medicines 2009 Amsterdam Elsevier
  3. [3]García-Cortés M Stephens C Lucena MI Fernández-Castañer A Andrade RJ Causality assessment methods in drug induced liver injury: Strengths and weaknesses J Hepatol 2011 55 683 691 21349301
  4. [4]Aithal GP Watkins PB Andrade RJ Larrey D Molokhia M Takikawa H Case definition and phenotype standardization in drug-induced liver injury Clin Pharmacol Ther 2011 89 806 815 21544079
  5. [5]Bunchorntavakul C Reddy KR Herbal and dietary supplement hepatotoxicity Aliment Pharmacol Ther 2013 37 3 17 23121117
  6. [6]Teschke R Schulze J Schwarzenboeck A Eickhoff A Frenzel C Herbal hepatotoxicity: suspected cases assessed for alternative causes Eur J Gastroenterol Hepatol 2013 in press 23510966
  7. [7]Teschke R Schwarzenboeck A Eickhoff A Frenzel C Wolff A Schulze J Clinical and causality assessment in herbal hepatotoxicity Expert Opin Drug Saf 2013 12 339 366 23458441
  8. [8]Danan G Consensus meetings on: causality assessment of drug-induced liver injury J Hepatol 1988 7 132 136 3053889
  9. [9]Teschke R Schwarzenboeck A Hennermann KH Causality assessment in hepatotoxicity by drugs and dietary supplements Br J Clin Pharmacol 2008 66 758 766 19032721 PMC2675778
  10. [10]Bénichou C Criteria of drug-induced liver disorders. Report of an international consensus meeting J Hepatol 1990 11 272 276 2254635
  11. [11]Danan G Bénichou C Causality assessment of adverse reactions to drugs – I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries J Clin Epidemiol 1993 46 1323 1330 8229110
  12. [12]Bénichou C Danan G Flahault A Causality assessment of adverse reactions to drugs – II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge J Clin Epidemiol 1993 46 1331 1336 8229111
  13. [13]Maria VA Victorino RM Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis Hepatology 1997 26 664 669 9303497
  14. [14]Aithal PG Day CP The natural history of histologically proved drug induced liver disease Gut 1999 44 731 735 10205214 PMC1727509
  15. [15]Aithal GP Rawlins MD Day CP Accuracy of hepatic adverse drug reaction reporting in one English health region BMJ 1999 319 1541 10591713 PMC28298
  16. [16]Takikawa H Takamori Y Kumagi T Onji M Watanabe M Shibuya A Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting Hepatol Res 2003 27 192 195 14585395
  17. [17]Rochon J Protiva P Seeff LB Fontana RJ Liangpunsakul S Watkins PB Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury Hepatology 2008 48 1175 1183 18798340 PMC3618289
  18. [18]Rockey DC Seeff LB Rochon J Freston J Chalasani N Bonachini M Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method Hepatology 2010 51 2117 2126 20512999 PMC3249230
  19. [20]Agbabiaka TB Savovic J Ernst E Methods for causality assessment of adverse drug reactions: A systematic review Drug Saf 2008 31 21 37 18095744
  20. [21]Tajiri K Shimizu Y Practical guideline for diagnosis and early management of drug-induced liver injury World J Gastroenterol 2008 14 6774 6785 19058303 PMC2773872
  21. [22]Karch FE Lasagna L Toward the operational identification of adverse drug reactions Clin Pharmacol Ther 1977 21 247 254 837643
  22. [23]Naranjo CA Busto U Sellers EM Sandor P Ruiz I Roberts EA A method for estimating the probability of adverse drug reactions Clin Pharmacol Ther 1981 30 239 245 7249508
  23. [25]Bégaud B Evreux JC Jouglard J Lagier G Unexpected or toxic drug reaction assessment (imputation). Actualization of the method used in France Therapie 1985 40 111 118 Article in French 4002188
  24. [26]Danan G Bénichou C Begaud B Biour M Couzigou P Evreux JC Criteria of causality of an acute hepatitis by drugs. Results of consensus meetings Gastroenterol Clin Biol 1987 11 581 585 3308618
  25. [27]Teschke R Frenzel C Schulze J Schwarzenboeck A Eickhoff A Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests World J Hepatol 2013 5 353 363 23898368 PMC3724963
  26. [28]Teschke R Frenzel C Schulze J Eickhoff A Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods World J Gastroenterol 2013 19 2864 2882 23704820 PMC3660812
  27. [32]Teschke R Bahre R Severe hepatotoxicity by Indian Ayurvedic herbal products: A structured causality assessment Ann Hepatol 2009 8 258 266 19841509
  28. [33]Teschke R Bahre R Fuchs J Wolff A Black cohosh hepatotoxicity: quantitative causality evaluation in nine suspected cases Menopause 2009 16 956 965 19339903
  29. [34]Teschke R Schwarzenboeck A Suspected hepatotoxicity by cimicifugae racemosae rhizoma (black cohosh, root): critical analysis and structured causality assessment Phytomedicine 2009 16 72 84 19010650
  30. [35]Kaplowitz N Causality assessment versus guilt-by-association in drug hepatotoxicity 2001 33 308 310 11124850
  31. [36]Lucena MI Camargo R Andrade RJ Perez-Sanchez CJ Sanches de la Cuesta F Comparison of two clinical scales for causality assessment in hepatotoxicity Hepatology 2001 33 123 130 11124828
  32. [37]Teschke R Fuchs J Bahre R Genthner A Wolff A Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment J Clin Pharm Ther 2010 35 545 563 20831679
  33. [38]Aithal GP Rawlins MD Day CP Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions J Hepatol 2000 33 949 952 11131457
  34. [39]Takikawa H Recent status of drug-induced liver injury and its problems in Japan Jap Med Ass J 2010 53 243 247 18637144
  35. [40]Macedo AF Marques FB Ribeiro CF Teixeira F Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability J Clin Pharm Ther 2003 28 137 143 12713611
  36. [41]Lee WM Assessing causality in drug-induced liver injury J Hepatology 2000 33 1003 1005 11131436
  37. [42]Watanabe M Shibuya A Validity study of a new diagnostic scale for drug-induced liver injury in Japan – comparison with two previous scales Hepatol Res 2004 30 148 154 15588780
  38. [43]Teschke R Wolff A Regulatory causality evaluation methods applied in kava hepatotoxicity: Are they appropriate? Regul Toxicol Pharmacol 2011 59 1 7 20854865
  39. [44]Fong TL Klontz KC Canas-Coto A Casper SJ Durazo FA Davern TJ Hepatotoxicity due to Hydroxycut: A case series Am J Gastroenterol 2010 105 1561 1566 20104221 PMC3825455
  40. [45]Fontana RJ Watkins PB Bonkovsky HL Chalasani N Davern T Serrano J Drug-induced liver injury Network (DILIN) prospective study: rationale, design and conduct Drug Saf 2009 32 55 68 19132805 PMC3637941
  41. [46]Chalasani N Fontana RJ Bonkovsky HL Watkins PB Davern T Serrano J Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States Gastroenterology 2008 135 1924 1934 18955056 PMC3654244
  42. [47]Davern TJ Chalasani N Fontana RJ Hayashi PH Protiva P Kleiner DE Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury Gastroenterology 2011 141 1665 1672 21855518 PMC3654540
  43. [48]Avelar-Escobar G Méndez-Navarro J Ortiz-Olvera NX Castellanos G Ramos R Gallardo-Cabrera VE Hepatotoxicity associated with dietary energy supplements: use and abuse by young athletes Ann Hepatol 2012 11 564 569 22700641
  44. [49]Andrade RJ Lucena MI Fernández MC Pelaez G Pachkoria K García-Ruiz E Spanish Group for the Study of Drug-induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period Gastroenterology 2005 129 512 521 16083708
  45. [50]Bessone F Hernandez N Dávalos M Paraná R Schinoni MI Lizarzabal M Building a Spanish-Latin American network on drug induced liver injury; much to get from a joint collaborative initiative Ann Hepatol 2012 11 544 549 22710943
  46. [51]Chau TN Cheung WI Ngan T Lin J Lee KWS Poon WT Causality assessment of herb-induced liver injury using multidisciplinary approach and the Roussel Uclaf Causality assessment Method (RUCAM) Clin Toxicol 2011 49 34 39 21114414
  47. [52]García-Cortés M Borraz Y Lucena MI Peláez G Salmerón J Diago M Liver injury induced by “natural remedies”: an analysis of cases submitted to the Spanish Liver Toxicity Registry Rev Esp Enferm Dig 2008 100 688 695 Article in Spanish 19159172
  48. [53]Teschke R Schulze J Suspected herbal hepatotoxicity: Requirements for appropriate causality assessment by the US Pharmacopeia Drug Saf 2012 35 1091 1097 22897137
  49. [54]Stammschulte T Gundert-Remy U Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: Was causality adequately ascertained? Regul Toxicol Pharmacol 2012 64 342 22728685
  50. [56]Manso G López-Rivas L Salgueiro ME Duque JM Jimeno FJ Andrade RJ Continuous reporting of new cases in Spain supports the relationship between Herbalife products and liver injury Pharmacoepidemiol Drug Saf 2011 20 1080 1087 21751292
  51. [57]Liss G Lewis JH Drug-induced liver injury: what was new in 2008? Expert Opin Drug Metab Toxicol 2009 5 843 860 19505188
  52. [58]Teschke R Schmidt-Taenzer W Wolff A Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: Is the liver unspecific Naranjo scale precise enough to ascertain causality? Pharmacoepidemiol Drug Saf 2011 20 567 582 21702069
  53. [59]García-Cortés M Lucena MI Pachkoria K Borraz Y Hidalgo R Andrade RJ Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injury Aliment Pharmacol Ther 2008 27 780 789 18284654
  54. [60]Teschke R Frenzel C Schulze J Eickhoff A Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: Was causality adequately ascertained? Regul Toxicol Pharmacol 2012 63 1 9 22381150
  55. [61]Teschke R Frenzel C Wolff A Herzog J Glass X Schulze J Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvements Ann Hepatol 2012 11 500 512 22700632
  56. [62]Teschke R Eickhoff A Wolff A Frenzel C Schulze J Herbal hepatotoxicity and WHO global introspection method Ann Hepatol 2013 12 11 21 23293189
  57. [63]Teschke R Glass X Schulze J Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): Causality assessment of 22 spontaneous reports Regul Toxicol Pharmacol 2011 61 282 291 21893153
  58. [64]Teschke R Glass X Schulze J Eickhoff A Suspected Greater Celandine hepatotoxicity: Liver specific causality evaluation of published case reports from Europe Eur J Gastroenterol Hepatol 2012 24 270 280 22189691
  59. [65]Agarwal VK McHutchison JG Hoofnagle JH Drug-Induced Liver Injury Network (DILIN). Important elements for the diagnosis of drug-induced liver injury Clin Gastroenterol Hepatol 2010 8 463 470 20170750 PMC3901223

Cited by

Sorted by citations

Metadata

Venue
Journal of Clinical and Translational Hepatology
Publisher
Xia & He Publishing
Published
2013-09-01
Volume
1
Issue
1
ISSN
  • 2225-0719
  • 2310-8819
DOI
10.14218/jcth.2013.d002x
PMC
PMC4521275
Cited by
10
References
0

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review